Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ambroxol-d5 is intended for use as an internal standard for the quantification of ambroxol (Item No. 19377) by GC- or LC-MS. Ambroxol is an expectorant and active metabolite of bromhexine.1 It inhibits the voltage-gated sodium channel Nav1.2 in isolated dorsal root neurons (IC50 = 110 µM for the rat channel).2 Ambroxol decreases short-circuit currents in electrically stimulated isolated canine tracheal epithelial cells when applied submucosally (IC50 = 60 nM).3 It decreases IL-13-induced production of mucin 5AC (MUC5AC) in primary human airway epithelial cells when used at a concentration of 100 µM and inhibits IL-13-induced decreases in the mucociliary transport rate of endogenous particles in the same cells.4 Ambroxol (30, 60, or 120 mg/kg) increases phenol red secretion, a marker of expectorant activity, in mice.5 Formulations containing ambroxol have been used in the treatment of acute or chronic respiratory conditions.
WARNING This product is not for human or veterinary use.
1. Ambroxol in the 21st century: Pharmacological and clinical update. Expert Opin. Drug Metab. Toxicol. 4(8), 1119-1129 (2008).
2. Comparison of the effects of four Na+ channel analgesics on TTX-
3. Ambroxol inhibits Na+ absorption by canine airway epithelial cells in culture. J. Pharm. Pharmacol. 43(12), 841-843 (1991).
4. Effects of guaifenesin, N-
5. Analytical and pharmacological validation of the quantification of phenol red in a mouse model: An optimized method to evaluate expectorant drugs. J. Pharmacol. Toxicol. Methods 98, 106586 (2019).